30 results
S-8
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
4 Jan 24
Registration of securities for employees
4:06pm
of a Participant’s employment for any reason, including retirement, death, disability, or the failure of a Participant to remain an eligible employee
S-8
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
4 Jan 24
Registration of securities for employees
4:06pm
Termination of Service. If the Participant’s Service terminates for any reason except for Cause or the Participant’s death or Disability … of the Participant’s Disability), then the Participant’s Options may be exercised only to the extent that such Options would have been exercisable
8-K
EX-14.1
DAWN
Day One Biopharmaceuticals Inc
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
identity or expression, transgender status, genetics, marital or veteran status, age, national origin, ancestry, physical disability (including HIV … /AIDS), mental disability, medical condition, pregnancy or child-birth (including breast-feeding), sexual orientation or any other characteristic
8-K
EX-1.1
DAWN
Day One Biopharmaceuticals Inc
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm
(A) from an employee of the Company upon death, disability or termination of employment, in each case, of such employee, or (B) pursuant to a right
424B5
7vh67ir0a00emgtdco
7 Jun 23
Prospectus supplement for primary offering
4:57pm
424B5
s2w4bn
6 Jun 23
Prospectus supplement for primary offering
4:21pm
PRE 14A
evvp0np
18 Apr 23
Preliminary proxy
4:05pm
S-8
EX-99.1
71jtrhfsswj z8h
31 Oct 22
Registration of securities for employees
4:07pm
8-K
EX-1.1
kznk4n
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
424B5
r75qitsrdldojy
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
j15d3 guc
14 Jun 22
Prospectus supplement for primary offering
7:39am
DEF 14A
s3olum93
28 Apr 22
Definitive proxy
4:44pm
10-K
EX-10.2
vuor1at46rvdn6vh
7 Mar 22
Annual report
7:36am
10-Q
EX-3.2
5evyylis01 i800r
10 Aug 21
Quarterly report
5:26pm
424B4
hjj3bo7 t2e
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
EX-10.3
iyl5b8ljwyno10
24 May 21
IPO registration (amended)
6:16am